Emergency Hemostatic Agent Industry Analysis By Sales, Revenue, Market Size, Share From 2017 To 2027 [MarketWatch]
Integra LifeSciences Holdings Corporation (IART)
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.integralife.com
Company Research
Source: MarketWatch
The Global Emergency Hemostatic Agent Market Industry Research provides Ethicon,Integra LifeSciences,C. R. Bard,Pfizer,Advanced Medical Solutions,Baxter International,Gelita Medical,Anika Therapeutics,The Medicines Company,B Braun Melsungen,CryoLife,Equimedical,BioCer Entwicklungs,Z-Medica,Vascular Solutions,Biom'Up SAS,Marine Polymer Technologies The MarketWatch News Department was not involved in the creation of this content. Dec 02, 2021 (Heraldkeepers) -- The most recent update of the “ Emergency Hemostatic Agent ” offers Detailed Analysis and Key Data factors on the Emergency Hemostatic Agent as Considered by the Top Market leaders for this Industry, Scope for Expansion and geographical outreach and overall market size for Emergency Hemostatic Agent with primary and secondary research and analysis of the important segments, market leading companies, and also regions. The study of 97 pages will provide an exhaustive and insightful overview of operations of the business functio
Show less
Read more
Impact Snapshot
Event Time:
IART
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IART alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IART alerts
High impacting Integra LifeSciences Holdings Corporation news events
Weekly update
A roundup of the hottest topics
IART
News
- Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024GlobeNewswire
- Here's Why Investors Should Retain Integra (IART) Stock Now [Yahoo! Finance]Yahoo! Finance
- Global Elbow Replacement Market to surpass $200.4 million by 2031, at a CAGR of 4.2%, says Coherent Market Insights [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at Citigroup Inc. from a "sell" rating to a "neutral" rating. They now have a $38.00 price target on the stock.MarketBeat
IART
Earnings
- 2/28/24 - Miss
IART
Sec Filings
- 4/4/24 - Form ARS
- 4/4/24 - Form DEF
- 3/25/24 - Form PRE
- IART's page on the SEC website